Board of Directors
Melissa B. Weimer, DO, MCR, DFASAM
Candidate for Secretary
Melissa B. Weimer, DO, MCR, DFASAM is an Associate Professor of Medicine and Public Health at Yale School of Medicine and Yale School of Public Health. She is a clinician-educator who is board certified in both Internal Medicine and Addiction Medicine.
She is the Director of the Yale Addiction Medicine Consult Service at Yale New Haven Hospital where she is active treating patients with complex substance use disorders. She is also Associate Program Director for the Yale Addiction Medicine Fellowship program which trains the next generation of physician leaders in Addiction Medicine.
Dr. Weimer has a clinical and research focus on improving the care of patients with addiction and its associated comorbidities, particularly in the hospital setting, and has specialty expertise in the treatment of complex pain. She is also passionate about expanding the workforce of healthcare professionals who can treat individuals with substance use disorders.
Dr. Weimer is a national leader in hospital-based addiction treatment models and expanding hospital-based addiction clinical care. She is a national leader in addiction education and has written and delivered curricula for health care professionals through the American Academy of Addiction Psychiatry Providers’ Clinical Support System, the newly released American Medical Association and American Society of Addiction Medicine Buprenorphine Mini-Course, and the Internal Medicine podcast called “Curbsiders”.
Dr. Weimer lectures nationally and regionally about addiction medicine, safe opioid use for pain, and hospital-based addiction care. She holds nationally recognized leadership positions through the American Society of Addiction Medicine on its national board and serves as the chairs of the Treatment of Substance Use Disorders Committee and the Clinical Practice Guidelines Methodology Committee.
Candidate Questionnaire Response
1. What have been your greatest contributions to ASAM or to the field of addiction medicine over the last 10 years?
Dr. Weimer has been active in ASAM since her fellowship in 2010, first participating in the ASAM Legislative Action Committee where she worked with other committee members to advocate for the expansion of federal funding for SUD treatment and the STAR SUD Loan Repayment program.
She then served as Region 1 Director to national ASAM from 2018-2020. Her current roles in ASAM for the last 2-3 years include member of the ASAM national board as Director at Large, Chair of the Treatment of Substance Use Disorder Education Committee, and Chair of the Clinical Practice Guideline Methodology subcommittee. She is an active member of the Medical Education Council and Quality Improvement Council.
Through all of these roles, she has been a leader to mainstream addiction treatment services in healthcare and expand the workforce of educated clinicians who treat SUD.
2. How would your election to the ASAM Board of Directors benefit ASAM and the field of addiction medicine?
Dr. Weimer is a nationally recognized leader in Addiction Medicine treatment, education, and research. Her role as the Secretary of ASAM, a position that sits on the Executive Council of the national board, will bring a diverse and informed perspective that is important for our influential organization.
Her leadership as the Chair of the Treatment of Substance Use Disorder Education Committee and Chair of the Clinical Practice Guideline Methodology subcommittee will ensure that issues related to quality, education and clinical practice guidelines are given sufficient consideration.
Dr. Weimer is committed to expanding equitable and accessible treatment for the diverse individuals that we treat, and she will remain grounded in this guiding principle in any role she serves within ASAM.